178 related articles for article (PubMed ID: 4985648)
1. Participation of nonspecific factors in the destruction of type M 12 streptococcus in vitro. I. Nonspecific absorption of anti-M 12 bactericidal activity.
Kahlich R; Procházka O
J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):75-87. PubMed ID: 4985648
[No Abstract] [Full Text] [Related]
2. Participation of nonspecific factors in destruction of type M12 streptococci in vitro. 3. A highly sensitive modification of the bactericidal test. Nonspecific coopsonin requirements.
Kahlich R; Procházka O
J Hyg Epidemiol Microbiol Immunol; 1971; 15(4):375-88. PubMed ID: 5170796
[No Abstract] [Full Text] [Related]
3. Participation of nonspecific factors in the destruction of type M12 streptococci in vitro. II. Indispensability of human complement and role of other factors in the bactericidal test.
Kahlich R
J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):172-83. PubMed ID: 5463710
[No Abstract] [Full Text] [Related]
4. Participation of nonspecific factors in destruction of type M 12 streptococci in vitro. IV. Detailed characteristics of nonspecific cofactor and its streptococcal receptor.
Kahlich R; Procházka O; Dubanská H
J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):412-25. PubMed ID: 4674091
[No Abstract] [Full Text] [Related]
5. Identification of type specific streptococcal antibodies by in vitro phagocytosis.
Bergner-Rabinowitz S; Beck A; Ofek I; Davies AM
Isr J Med Sci; 1969; 5(3):285-92. PubMed ID: 5821820
[No Abstract] [Full Text] [Related]
6. Incidence of cellular and humoral factors on group A streptococcal L forms. II. Killing effect of sera and phagocytic cells.
Drach G; Schmitt-Slomska J
Ann Microbiol (Paris); 1973 Dec; 124(4):463-76. PubMed ID: 4599958
[No Abstract] [Full Text] [Related]
7. Complex surveillance of Streptococcus pyogenes. III. Immunological characteristics of streptococcal resistance in blood and new aspects of type nonspecific protection.
Kahlich R
J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):61-75. PubMed ID: 772126
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
Root RK; Ellman L; Frank MM
J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402
[No Abstract] [Full Text] [Related]
9. Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.
Mortimer GE; Widdowson JP
Clin Exp Immunol; 1979 Aug; 37(2):247-58. PubMed ID: 498585
[TBL] [Abstract][Full Text] [Related]
10. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
11. [The specificity of bactericidal effect and phagocytosis as regulatory mechanism in the protection from infection].
Stelzner A; Koch H; Treichel C
Allerg Immunol (Leipz); 1973; 19(2-4):189-91. PubMed ID: 4281623
[No Abstract] [Full Text] [Related]
12. Cross-reactive antigens of bovine streptococci.
Stark DM
Cornell Vet; 1971 Oct; 61(4):617-24. PubMed ID: 5166134
[No Abstract] [Full Text] [Related]
13. Purified group a streptococcal M-protein in latex agglutination for detection of type-specific M-antibodies.
Erwa HH
Afr J Med Sci; 1973 Oct; 4(4):479-90. PubMed ID: 4792061
[No Abstract] [Full Text] [Related]
14. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
Bjornson AB; Michael JG
J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
[No Abstract] [Full Text] [Related]
15. Cross-reactions among group A streptococci. 3. The M and R antigens of type 43 and serologically related streptococci.
Wil GG; Bruno PN
J Immunol; 1970 Nov; 105(5):124-30. PubMed ID: 4099052
[No Abstract] [Full Text] [Related]
16. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
STOLLERMAN GH; RYTEL M; ORTIZ J
J Exp Med; 1963 Jan; 117(1):1-17. PubMed ID: 13984363
[TBL] [Abstract][Full Text] [Related]
17. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus somnus complex: in vitro interactions of Haemophilus somnus, leukocytes, complement, and antiserums produced from vaccination of cattle with fractions of the organism.
Pennell JR; Renshaw HW
Am J Vet Res; 1977 Jun; 38(6):759-69. PubMed ID: 879574
[No Abstract] [Full Text] [Related]
19. Opsonic capacity of type specific streptococcal antibodies.
Ofek I; Bergner-Rabinowitz S; Davies AM
Isr J Med Sci; 1969; 5(3):293-6. PubMed ID: 4980691
[No Abstract] [Full Text] [Related]
20. [Change in body reactivity under the effect of penicillin in the induction phase of experimental streptococcal infection].
Leshchenskiĭ AF; Zuza ZI; Pavlova ES
Antibiotiki; 1971 Jul; 16(7):636-41. PubMed ID: 4945576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
